Cashu | News | REGN

HomeWatchlistNewsSignalsPicks

DJI

+1.36%

SPX

+0.85%

IXIC

+0.72%

FTSE

+0.78%

N225

0.00%

AXJO

0.00%

HomeWatchlistNewsSignalsPicks

Stocks

0.00 (0.00%)

0.000

USD

At close at --,----

Cashu is the #1 way to stay ahead of the markets, know why your favourite stocks are moving and access valuation signals that smash the market.

Company

About Us
Careers
Blog
News

Help & Support

Help Center
Contact Us
Pro Support

Legal

Privacy Policy
Terms of Use

Instagram YouTube

© 2024 Cashu PTY LTD.

Join our newsletter to keep up to date with us!

Latest Regeneron Pharmaceuticals News

What's Happening With Regeneron Pharmaceuticals Stock On Monday?

Feature Image for interests on Ai Generated, Biotech, Healthcare, Large Cap from benzinga.com

Sanofi Hit With Shock As Flagship Drug Successor Disappoints Investors

Feature Image for interests on Biotech, Expert Ideas, Financial Services, Healthcare from benzinga.com

Here are Wednesday's biggest analyst calls: Apple, Alphabet, Chipotle, Western Digital, McDonald's & more

Feature Image for interests on Basic Materials, Breaking News: Investing, Breaking News: Markets, Consumer Cyclical from cnbc.com

Where Regeneron Pharmaceuticals Stands With Analysts

Regeneron Advances In Rare Disease Race With Positive Autoimmune Muscle Disorder Trial Data

Feature Image for interests on Biotech, Health Care, Healthcare, Iran from benzinga.com

FDA Flags Alarming Contamination At Novo Nordisk Indiana Plant, Including Cat Hair, Bacteria, And Foreign Particles

A new pharma factory shows how hard it could be for drugmakers to outrun Trump's tariffs

Feature Image for interests on Biotech And Pharmaceuticals, Healthcare, Stock, Trade from cnbc.com

Here are Thursday's biggest analyst calls: Nvidia, Amazon, AMD, Cisco, CoreWeave, Sunrun & more

Feature Image for interests on Basic Materials, Breaking News: Investing, Breaking News: Markets, Consumer Cyclical from cnbc.com

Demystifying Intellia Therapeutics: Insights From 9 Analyst Reviews

about 1 month ago

A Look Into Regeneron Pharmaceuticals Inc's Price Over Earnings

about 1 month ago

Latest Cashu News

Regeneron Pharmaceuticals Achieves Major Breakthrough in Allergy Treatment Trials

about 9 hours ago

Regeneron Pharmaceuticals Achieves Success in Phase 3 Allergy Treatment Trials

Regeneron Pharmaceuticals: Seizing Opportunities in Turbulent Dermatology Market Post-Sanofi Setbacks

Stocks

Health Care

regn

Regeneron Pharmaceuticals

NASDAQ: REGN

+12.34 (+2.22%)

568.175

USD

At close at Sep 11, 20:36 UTC